News for '-commercialisation'

'No CAA', govt jobs among Rahul's 5 promises to Assam

'No CAA', govt jobs among Rahul's 5 promises to Assam

Rediff.com19 Mar 2021

Congress leader Rahul Gandhi on Friday assured that the Citizenship Amendment Act (CAA) will not be implemented in Assam if the party is voted to power in the state in the coming assembly poll.

Bharat Biotech to produce 700 mn Covaxin doses annually

Bharat Biotech to produce 700 mn Covaxin doses annually

Rediff.com20 Apr 2021

The Hyderabad-based manufacturer uses a proprietary adjuvant Algel-IMDG, which has now proven to be a safe and effective adjuvant, especially to stimulate memory T cell responses.

Sabyasachi first Indian to win National Intellectual Property Award 2018

Sabyasachi first Indian to win National Intellectual Property Award 2018

Rediff.com27 Apr 2018

Sabyasachi Couture is recognised for its contribution to the design industry.

Lalit Modi Was Born To Take Risks

Lalit Modi Was Born To Take Risks

Rediff.com30 Jul 2022

The IPL, which was perhaps the biggest gamble of his life, turned out to be the biggest success story ever, making Lalit Modi a cult in the echelons of global sport.

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

How Shah Rukh Khan Became Baazigar

How Shah Rukh Khan Became Baazigar

Rediff.com26 May 2022

'When we finished the narration, we expected Shah Rukhbhai to say the usual, 'I'll think about it and let you know in two days.' But he jumped up and said, 'I'm doing the film.'

The Kerala You Should Discover

The Kerala You Should Discover

Rediff.com3 Aug 2022

Kerala will be one of those places where the line between tourism, a land, a people and their way of life will blur. It won't be tourism; it will be a visit to experience Kerala.

USFDA denies Covaxin emergency use nod, to take 'full approval' route

USFDA denies Covaxin emergency use nod, to take 'full approval' route

Rediff.com11 Jun 2021

In a setback that could potentially delay the launch of Bharat Biotech's Covid-19 vaccine Covaxin in USA, the Food and Drug Administration there has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation.

Cabinet clears Rs 76,000-crore incentive scheme for semiconductors

Cabinet clears Rs 76,000-crore incentive scheme for semiconductors

Rediff.com15 Dec 2021

The Union Cabinet on Wednesday approved a Rs 76,000 crore policy boost for semiconductor and display manufacturing ecosystem in the country in an bid to position India as a global hub for hi-tech production. Announcing the decision of the Cabinet, IT and Telecom Minister Ashwini Vaishnaw observed that electronics plays an important role in everyday life, and semiconductor chips forms a crucial part of electronics. Outlining the details of the scheme, he said the Rs 76,000 crore programme has been approved for the development of semiconductors and display manufacturing ecosystem.

Alibaba puts Internet in cars, plans to take drivers out

Alibaba puts Internet in cars, plans to take drivers out

Rediff.com6 Jul 2016

The race to commercialise driverless cars is far from over with experts predicting that a fully autonomous car will not hit the market until 2020 or later

Biocon inks pact with Mylan

Biocon inks pact with Mylan

Rediff.com14 Feb 2013

The Bengaluru-based firm has entered into a definitive agreement with Mylan for an exclusive strategic collaboration for the global development and commercialisation of generic versions of its three insulin analog products, Biocon Ltd said in a statement.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Why Indians Study Medicine In Ukraine

Why Indians Study Medicine In Ukraine

Rediff.com2 Mar 2022

'With over 50 per cent of medical seats reserved for those who have the ability to pay a fee ranging from Rs 50 lakh to Rs 1.5 crore for a five-year MBBS course and quotas in accordance with affirmative policies in government colleges, the band of seats available for the not-so-rich and non-OBCs is very narrow.'

Modi raises H-1B visas issue with Biden: Foreign Secretary Shringla

Modi raises H-1B visas issue with Biden: Foreign Secretary Shringla

Rediff.com25 Sep 2021

Prime Minister Narendra Modi in his first-ever in-person meeting with President Joe Biden raised a number of issues involving the Indian community in America, including access for Indian professionals in the US and speaking about the H-1B visas, Foreign Secretary Harsh Vardhan Shringla has said.

Govt panel recommends nod for phase 2/3 trials of Covovax on kids

Govt panel recommends nod for phase 2/3 trials of Covovax on kids

Rediff.com27 Jul 2021

An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covid vaccine Covovax on children aged 2 to 17 years with certain conditions, official sources said.

Hopeful of launching Covovax by Oct: Adar Poonawalla

Hopeful of launching Covovax by Oct: Adar Poonawalla

Rediff.com6 Aug 2021

On production capacity of Covishield, the vaccine being manufactured and supplied by Serum in India under a licensing agreement with Oxford and AstraZeneca, he said the present capacity is 130 million doses per month and always try to increase it further.

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

ICC announced IPL not T20 team: Shoaib Akhtar

ICC announced IPL not T20 team: Shoaib Akhtar

Rediff.com27 Dec 2020

Pakistan players did not find any spot in ICC Team of the Decade across all formats

Rediff.com columnist Ambassador T P Sreenivasan attacked in Kerala

Rediff.com columnist Ambassador T P Sreenivasan attacked in Kerala

Rediff.com29 Jan 2016

Marxist 'students' attack former diplomat.

DCGI approves commercial launch of low-cost Covid test 'Feluda'

DCGI approves commercial launch of low-cost Covid test 'Feluda'

Rediff.com20 Sep 2020

This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus, CSIR said in a statement.

Ambani forays into green energy biz; to invest Rs 75,000 cr

Ambani forays into green energy biz; to invest Rs 75,000 cr

Rediff.com24 Jun 2021

Reliance Industries Ltd on Thursday announced a Rs 75,000 crore investment in new energy business over the next three years as the operator of the world's largest oil refinery pivots towards a greener and cleaner version. Reliance will build solar manufacturing units, a battery factory for energy storage, a fuel cell-making plant and an electrolyzer unit to produce green hydrogen as a part of the business, chairman Mukesh Ambani said at the company's annual general meeting with shareholders on Thursday. It will also set up 100 gigawatts (GW) of solar power generation capacity by 2030 and invest in setting up a carbon fibre plant.

Is cricket moving in the right direction?

Is cricket moving in the right direction?

Rediff.com30 Apr 2020

Looking to suck out every dollar available, cricket was suffering from an overkill and the coronavirus-forced break should be used to introspect whether the game is heading in the right direction, says West Indies fast bowling great Michael Holding. The 66-year-old cricketer-turned-commentator personally believes hitting the pause button for a while was necessary amid excessive commercialisation of the sport.

This Budget Is Harder Than Last Year's

This Budget Is Harder Than Last Year's

Rediff.com28 Jan 2022

The challenges before the coming Budget are more daunting than those in 2021, reveals A K Bhattacharya.

Indian scientists develop low-cost COVID-19 test, Feluda

Indian scientists develop low-cost COVID-19 test, Feluda

Rediff.com22 Apr 2020

Named after 'Feluda', the detective character in legendary filmmaker Satyajit Ray's stories, the test has been developed by Debojyoti Chakraborty and Souvik Maiti as a simpler way of detecting SARS-coV2 presence in clinical samples, IGIB Director Anurag Agarwal said.

ARIIA: A true sangam of Lakshmi and Saraswati

ARIIA: A true sangam of Lakshmi and Saraswati

Rediff.com5 Sep 2018

'If India has to emerge as the world's laboratory and a global innovation hub, the minds of our youngsters must get an opportunity to flourish.'

Google doodles chemist Sir William Henry Perkin

Google doodles chemist Sir William Henry Perkin

Rediff.com12 Mar 2018

Perkin is credited with discovering synthetic dye at a young age of 18.

DRDO hands over civilian tech to Baba Ramdev to sell

DRDO hands over civilian tech to Baba Ramdev to sell

Rediff.com24 Aug 2015

India's premier defence research organisation, DRDO has now roped in yoga guru Ramdev's Patanjali Ayurveda Limited to manufacture and market in the country and abroad some herbal supplements and food products developed by it.

NEP, 4-year undergrad programme gets DU's implementation approval

NEP, 4-year undergrad programme gets DU's implementation approval

Rediff.com1 Sep 2021

The implementation of the NEP and four-year undergraduate programme were approved by the Standing Committee on Academic Matters and the Academic Council last week.

Why new IPL title sponsor may not be highest bidder

Why new IPL title sponsor may not be highest bidder

Rediff.com10 Aug 2020

The new IPL title sponsor to replace Chinese mobile phone company VIVO will hold the rights for only a four-and-a-half-month period and the highest bid may not necessarily end up being the winning one, the BCCI stated on Monday.

Should ICC separate women's media rights?

Should ICC separate women's media rights?

Rediff.com3 Apr 2020

ICC shared impressive television broadcast, digital audience and attendance numbers from the tournament on Thursday, which it said have set 'new benchmarks'. According to ICC estimates, 70% of the game's billion-plus fans want to see more women's cricket, which resulted in 1.1 billion video views for the tournament in Australia.

Infosys to acquire US-based Kaleidoscope Innovation

Infosys to acquire US-based Kaleidoscope Innovation

Rediff.com3 Sep 2020

It designs microsurgical instruments, devices used in minimally invasive surgery, drug delivery devices for ophthalmic therapies and user-centric wearables.

With coronavirus still around, 'virus killers' hit the market

With coronavirus still around, 'virus killers' hit the market

Rediff.com7 Sep 2020

A gamechanger for offices and factories, Shycocan, claims to be able to clear an area of 1000 square feet from coronavirus.

US students who took Covaxin, Sputnik asked to get re-vaccinated

US students who took Covaxin, Sputnik asked to get re-vaccinated

Rediff.com4 Jun 2021

These vaccines have not yet been approved by the World Health Organization

Japan denies considering vaccine priority for Olympic athletes

Japan denies considering vaccine priority for Olympic athletes

Rediff.com13 Apr 2021

New infections have spiked ahead of the Olympics, which are set to start in July

India may get COVID-19 vaccine by early 2021: Report

India may get COVID-19 vaccine by early 2021: Report

Rediff.com28 Aug 2020

While the vaccine could be available at $3-6 (Rs 225 to Rs 550) per dose, herd immunity might be two years away due to implementation challenges, it said, adding the experience in large scale adult vaccination programmes is thin.

'I don't do things out of insecurity'

'I don't do things out of insecurity'

Rediff.com1 Dec 2021

'We were not trying to outshine each other, we were just trying to be sincere and honest to what was given.' 'We spent quality time with each other, so there was no room for any negativity or insecurity.'

SpaceX may test-run its supersonic train in Pune

SpaceX may test-run its supersonic train in Pune

Rediff.com13 Sep 2016

Hyperloop runs faster than an aircraft at a speed of 1,120 kmph and can cut the distance between Nagpur and Mumbai in 35 minutes

Black pearl making tech to hit market soon

Black pearl making tech to hit market soon

Rediff.com4 Jul 2007

A self-taught Indian scientist, who has produced the world's largest black pearl is looking to commercialise his pearl culture technique that has the potential to change the profile of the country's gem and jewellery exports in a single stroke.

PlanetSpace inks space tourism deal with NASA

PlanetSpace inks space tourism deal with NASA

Rediff.com3 Feb 2007

The company said this would boost their efforts to send tourists to space by 2009 and help quick point-to-point travel across the earth using a space vehicle.

Dr Reddy's to sell Torrent drugs in Russia

Dr Reddy's to sell Torrent drugs in Russia

Rediff.com30 Nov 2006

Torrent Pharma, the pharmaceuticals major, has entered into a pact with Dr Reddy's Laboratories for exclusive commercialisation of two of its brands in Russia.